MASLD and MASH: Early Identification to Decrease Associated Complications

Starts 8/19/2024 | Expires 8/19/2025

Access our free online course designed to equip healthcare professionals with the latest knowledge and tools to effectively identify and manage patients at risk for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) . Through this program, participants will gain essential skills to decrease the associated complications of these conditions.

Course Description

Course Highlights

Identify At-Risk Patients: Learn to recognize patients with risk factors for MASLD and MASH, including those with prediabetes, diabetes, obesity, and other metabolic comorbidities.
Non-Invasive Screening Techniques: Utilize current non-invasive tests to enhance early screening efforts and identify when specialist referrals are necessary.
Data Interpretation: Implement and refine the interpretation of non-invasive test data for optimal management strategies and patient follow-up.
Emerging Therapies: Discover existing and emerging pharmacotherapies that can improve outcomes for MASLD, MASH, and associated comorbidities.

Learning Objectives:

Upon successful completion of the program, participants should be able to:

Identify patients with risk factors for MASLD.
Utilize currently available non-invasive tests for early screening and identify when referrals to specialists are needed.
Implement and improve data interpretation of non-invasive tests for best management strategies and follow-up of patients.
Identify existing and emerging pharmacotherapies that can assist in improving both MASLD and MASH and other comorbidities.

Format:
Lectures
Patient Cases

Tagret Audience:

This educational program is ideal for healthcare professionals involved in the care of patients at risk for MASLD and MASH, including:

Endocrinologists
Primary Care Physicians (PCPs)
Advanced Practice Professionals (Nurse Practitioners [NPs], Physician Assistants [PAs]

Learning Objectives

Upon successful completion of the program, participants should be better able to:

Identify patients with risk factors for MASLD.
Utilize currently available non-invasive tests for early screening and identify when referrals to specialists are needed.
Implement and improve data interpretation of non-invasive tests for best management strategies and follow-up of patients.
Identify existing and emerging pharmacotherapies that can assist in improving both MASLD and MASH and other comorbidities.

Target Audience

This educational program is ideal for healthcare professionals involved in the care of patients at risk for MASLD and MASH, including:

Endocrinologists
Primary Care Physicians (PCPs)
Advanced Practice Professionals (Nurse Practitioners [NPs], Physician Assistants [PAs]

Accreditation and Designation Statements

Physicians and Physician Assistants
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared.

Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 3.5 contact hours.

Commercial Support

This activity is supported by independent educational grants from Novo Nordisk and Siemens Medical Solutions

Purchase URL

https://my.aace.com/NC__Product?id=a1BPo0000037fntMAA

Price

FREE

Group

ENDO, PCP, NP, PA

Summary


Availability:	On-Demand
	Expires on Aug 19, 2025


Cost:	FREE


Credit Offered:	2 CME Credits 2 Nursing Credits 2 ABIM-MOC Points 2 ABOM Credits

Recommended

Clinical Conversations in Diabetes Technology: Resources and Acceptance

Starts 5/31/2024 | Expires 5/31/2025

This initiative is designed to help primary care clinicians establish practice-level strategies for enhancing patient-centered care of diabetes with diabetes technology.  The educational strategies learned through this program will address the opportunities for implementation in practices of various sizes and resources.

Multiple Credits

FREE

(8)

GLP-1 RA’s Role in the Management of Diabetes: Tools for the Primary Care Professional

Starts 10/31/2024 | Expires 10/31/2025

This program aims to equip primary care professionals with the skills to manage type 2 diabetes more effectively, particularly those who may be hesitant to prescribe glucagon-like peptide-1 receptor agonists (GLP-1 RAs).

Multiple Credits

FREE

(4)

Activating Obesity Diagnosis

Non CME No Expiration

Obesity is one of the most prevalent non-communicable chronic diseases in the world. Many people with obesity attempt to lose weight each year; however, only a small percentage can achieve and maintain long-term weight loss. Despite its prevalence and effects on health, obesity remains largely underdiagnosed and undertreated, and few clinicians have the confidence or training to manage obesity effectively in their patients, indicating a significant need for education.

No Credit

FREE

(25)

AACE Rare Endocrine Disease Series On Demand: Acromegaly Puzzle - Clinical Clues to Earlier Diagnosis Challenges and Treatment Options

Starts 10/21/2024 | Expires 10/21/2025

AACE Rare Endocrine Disease Series is pleased to present Acromegaly Puzzle: Clinical Clues to Earlier Diagnosis Challenges and Treatment Options, a course designed to help clinicians create a path to diagnosis when encountering a patient with acromegaly.

Multiple Credits

FREE

AACE Rare Endocrine Disease Series On Demand: Are these Changes in my Health Significant? Identifying and Treating Cushing’s Syndrome

Starts 10/14/2024 | Expires 10/14/2025

AACE Rare Endocrine Disease Series is pleased to present Are these Changes in my Health Significant? Identifying and Treating Cushing’s Syndrome, a course designed to help clinicians create a path to diagnosis when encountering a patient with Cushing's Syndrome.

Multiple Credits

FREE

AACE Rare Endocrine Disease Series On Demand: Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease

Starts 10/7/2024 | Expires 10/7/2025

AACE Rare Endocrine Disease Series is pleased to present Recognizing and Treating X-Linked Hypophosphatemia a Lifelong Progressive Disease, a course designed to help clinicians create a path to diagnosis when encountering a patient with x-linked hypophosphatemia.

Multiple Credits

FREE

(2)

AACE Rare Endocrine Disease Series On Demand: Fatigue, Abnormal Body Composition and Bone Loss: Is Adult GHD to Be Blamed?

Starts 10/28/2024 | Expires 10/28/2025

AACE Rare Endocrine Disease Series is pleased to present Fatigue, Abnormal Body Composition and Bone Loss: Is Adult GHD to Be Blamed? This course is designed to help clinicians create a path to diagnosis when encountering a patient with growth hormone deficiency.

Multiple Credits

FREE

(1)